Trial intelligence / Profile preview

Bioequivalence study of Zonnic nicotine gum versus Nicorette nicotine gum in healthy smokers

2008-007238-23Phase 4Completed

Sponsor
Niconovum
Start
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by Niconovum. Primary endpoint: Plasma nicotine levels. Started Dec 2008; status: completed.

02

Drugs

nicotine
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2008-007238-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-007238-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call